Hi 2020
Thanks for that reply,
It is still early days for Favipiravir imho, we have seen what is now happening with peramivir, when first it was hailed as the next great antiviral and now resistance seem to be a serious issue.
Only time will tell, but its good to keep a close eye on possible future contenders who could take market share away from Biota.
jojo
- Forums
- ASX - By Stock
- BTA
- could favipirivir become a serious contender